Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03428373
Title ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy. (RithMM)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Lawson Health Research Institute
Indications

multiple myeloma

Therapies

Dexamethasone + Lenalidomide + Rivaroxaban

Aspirin + Dexamethasone + Lenalidomide

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.